Loading...
Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage
BACKGROUND: It is unknown whether ribavirin (RBV) coadministration modifies the early rate of decline of hepatitis C virus (HCV) RNA in the liver versus plasma compartments, specifically. METHODS: This partially randomized, open-label, phase 2 study enrolled treatment-naive, noncirrhotic patients wi...
Na minha lista:
| Udgivet i: | J Infect Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5853515/ https://ncbi.nlm.nih.gov/pubmed/29228392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jix495 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|